Lysine sulfonamides as novel HIV-protease inhibitors: Nε-disubstituted ureas
摘要:
A series of lysine sulfonamide analogues bearing a Nepsilon-benzylic ureas was synthesized using both solution-phase and solid-phase approaches. A novel synthetic route of Nalpha-(alkyl)-Nalpha-(sulfonamides)lysinol using alpha-amino-caprolactam was developed. Evaluation of these novel protease inhibitors revealed compounds with high potency against wild-type HIV virus. (C) 2004 Elsevier Ltd. All rights reserved.
Nickel-catalyzed hydrogenative coupling of nitriles and amines for general amine synthesis
作者:Vishwas G. Chandrashekhar、Wolfgang Baumann、Matthias Beller、Rajenahally V. Jagadeesh
DOI:10.1126/science.abn7565
日期:2022.6.24
Efficient and general methods for the synthesis of amines remain in high demand in the chemical industry. Among the many known processes, catalytic hydrogenation is a cost-effective and industrially proven reaction and currently used to produce a wide array of such compounds. We report a homogeneous nickel catalyst for hydrogenative cross coupling of a range of aromatic, heteroaromatic, and aliphatic
UREA DERIVATIVES AS HIV ASPARTYL PROTEASE INHIBITORS
申请人:Ambrilia Biopharma Inc.
公开号:EP1480941B1
公开(公告)日:2011-01-26
US6528532B1
申请人:——
公开号:US6528532B1
公开(公告)日:2003-03-04
[EN] UREA DERIVATIVES AS HIV ASPARTYL PROTEASE INHIBITORS<br/>[FR] DERIVES DE L'UREE INHIBITEURS DE L'ASPARTYL PROTEASE DU VIH
申请人:PHARMACOR INC
公开号:WO2003074467A2
公开(公告)日:2003-09-12
The present invention provides HIV aspartyl protease inhibitors of the formula (I): and when the compound of formula I comprises an amino group, pharmaceutically acceptable ammonium salts thereof, wherein n is 3 or 4, Y is O, S, NH or N-CN, wherein Cx may be, for example COOH, or CH20H, wherein R1 is selected from the group consisting of a benzenesulfonyl group of formula II as defined herein, wherein R2 may be, for example, iso-butyl, or 3-methylbutyl, and wherein R3 and R4 areas defined herein.